[Hematology 2009].
Dreyling
M
M
Medizinische Klinik III der Universität München - Grosshadern, München. martin.dreyling@med.uni-muenchen.de
Spiekermann
K
K
Hiddemann
W
W
D019337:Hematologic Neoplasms / Q000145:classification / Q000175:diagnosis* / Q000628:therapy; D006405:Hematology / Q000639:trends*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000628:therapy; D015470:Leukemia, Myeloid, Acute / Q000175:diagnosis; D008224:Lymphoma, Follicular / Q000628:therapy; D016403:Lymphoma, Large B-Cell, Diffuse / Q000628:therapy; D009101:Multiple Myeloma / Q000628:therapy; D011379:Prognosis; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000175:diagnosis / Q000628:therapy; D054556:Venous Thromboembolism / Q000517:prevention & control
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors